Close Menu

NIAID

The software firm will use NGS data from patient biopsies to create molecular profiles and offer individualized cancer treatment recommendations.

Its most advanced gene expression signatures are for infectious disease diagnostics and are aimed at enabling the appropriate prescription of antiviral and antibiotic medications.

A new analysis finds that better grant-writing skills may help early-career researchers stay funded and stay in academia.

The company said it will use the funding to accelerate the development of an affordable sequencing test for metagenomic samples.

The new centers will generate genomic resources and tools for infectious disease research.

In PLOS this week: hierarchical fine-mapping approach, genomic and sub-genomic variations in lab porcine epidemic diarrhea virus strains, and more.

First Stages

Early trial of experimental gene-based Zika vaccine indicates it is tolerated and leads to an antibody response.

The grant is specifically intended to support the development of noninvasive, rapid tests that can be used at the point of care in developing country settings.

An exome sequencing analysis of individuals from eight families led to homozygous loss-of-function mutations in CD55 and ties to complement system activity.

After identifying mutations in CARD11 in individuals with severe atopic dermatitis, investigators began untangling potential signaling consequences.

Pages

Russian CRISPR researcher moves along with plans to ultimately alter the genes of embryos of deaf couples, though awaits regulatory approval, Nature News reports.

University of California, San Francisco, researchers have uncovered a gene mutations that appears to make a father-son duo more efficient sleepers.

NPR reports a large health insurer has begun to cover some pharmacogenetic tests for psychiatric drugs.

In PLOS this week: genome-wide association study of non-syndromic orofacial cleft subtypes, epigenetic and transcriptomic analysis of pancreatic ductal adenocarcinoma, and more.